Boston Scientific Corp
NYSE: BSX
$89.25
-$0.75 (-0.8%)
Closing Price on November 25, 2024
BSX Articles
Tuesday was a very strong day for U.S. broad markets in general, with each major index hitting a new all-time high. This incredible boost came from the Senate Budget Committee advancing the tax bill....
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include Boston Scientific, Cleveland-Cliffs, GE, Hasbro, Illumina, T-Mobile, United Continental, Seagate.
Published:
Last Updated:
Despite the concerns over the struggles of politicians to craft a new health care plan for the United States, the health care sector, and many of its subsectors, have had an outstanding first half to...
Published:
Last Updated:
Once again last week the market was hitting all-time highs, and once again insiders were selling shares at a furious pace. Who can blame them?
Published:
Last Updated:
Boston Scientific reported its third-quarter financial results before the markets opened on Wednesday.
Published:
Last Updated:
If the independent research firm Argus is correct, then Boston Scientific shareholders could see an upside of roughly 40% from the current price level.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Boston Scientific, Micron Technology, Salesforce.com, TransCanada and Walgreens Boots Alliance.
Published:
Last Updated:
When Boston Scientific reported second-quarter results Wednesday, revenues were up 10% overall, with medical and surgical product sales up nearly 30%.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday morning include Alcoa, Boston Scientific, Schlumberger, Sony and Staples.
Published:
Last Updated:
Merrill Lynch has some ideas about how to take advantage of the trends in health care going forward.
Published:
Last Updated:
Despite the market rally, insiders are still buying at big levels, while insider selling remains dormant. This is a very positive sign for equity investors and the market as a whole.
Published:
Last Updated:
While the natural inclination is to think that corporate executives would like to sell stock into a big market rally like the one this past week, the data sure didn’t confirm that.
Published:
Last Updated:
Last week, a few biotech companies made absolutely massive runs, and some had serious falls.
Published:
Last Updated:
Boston Scientific reported better-than-expected third-quarter financial results before the markets opened on Wednesday.
Published:
Monday's top analyst upgrades, downgrades and initiations include AutoZone, Discover Financial Services, IBM, Microsoft, Twitter, Viacom and Wynn Resorts.
Published: